Mometasone

Active ingredient: Mometasone Furoate

In short: Mometasone furoate ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age or older.

Forms & strengthsOintment, 0.1%. Each gram of Mometasone Furoate Ointment USP, 0.1% contains 1 mg of mometasone furoate in a white to off-white uniform ointment base.
LabelPadagis Israel Pharmaceuticals Ltd
Label updatedSep 02, 2026

What is Mometasone used for?

Mometasone furoate ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age or older.

Mometasone dosage

•Mometasone furoate ointment is for topical use only. It is not for oral, ophthalmic, or intravaginal use.

•Apply a thin film of mometasone furoate ointment to the affected skin areas once daily. Avoid use on the face, groin, or axillae. Wash hands after each application.

•Avoid contact with eyes .

•Do not use mometasone furoate ointment with occlusion. Do not use mometasone furoate ointment in the treatment of diaper dermatitis.

•Discontinue therapy when control is achieved.

•If no improvement is seen within 2 weeks, consider reassessment of diagnosis .

How to take Mometasone — instructions & advice from the label

Advise the patient to read the FDA-approved patient labeling (Patient Information).

Important Administration Instructions

Inform patients of the following :

•Use mometasone furoate ointment as directed by the healthcare provider. It is for external use only. Wash hands after use.

•Discontinue therapy when control is achieved. If no improvement is seen within 2 weeks, contact the healthcare provider.

•Avoid contact with the eyes.

•Avoid using mometasone furoate ointment on the face, underarms, or groin areas.

•Do not bandage or otherwise cover or wrap the treated skin area so as to be occlusive. Do not use mometasone furoate ointment in the treatment of diaper dermatitis.

Endocrine System Adverse Reactions

•Advise patients that mometasone furoate ointment may cause HPA axis suppression. Inform patients that use of topical corticosteroids, including mometasone furoate ointment, may require periodic evaluation for HPA axis suppression. Topical corticosteroids may have other endocrine effects. Instruct patients not to use other corticosteroid-containing products while using mometasone furoate ointment without first consulting their healthcare provider . …

Warnings & precautions

Do not take this medicine if: Mometasone furoate ointment is contraindicated in patients with a history of hypersensitivity to mometasone furoate or any of the excipients in mometasone furoate ointment.

Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression

Systemic absorption of topical corticosteroids, including mometasone furoate ointment, can cause reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency. This may occur during treatment or after withdrawal of treatment. Factors that predispose a patient using a topical corticosteroid to HPA axis suppression include the use of high-potency corticosteroids, large treatment surface areas, prolonged use, use of occlusive dressings, altered skin barrier, liver failure, and young age.

Because of the potential for systemic absorption, consider periodically evaluating patients who are at risk of HPA axis suppression for evidence of HPA axis suppression. This may be done by using the adrenocorticotropic hormone (ACTH) stimulation test.

In a trial evaluating the effects of mometasone furoate ointment on the HPA axis, 15 grams were applied twice daily for 7 days to 6 adult subjects with psoriasis or atopic dermatitis. In this trial, mometasone furoate ointment caused a slight lowering of adrenal corticosteroid secretion .

If HPA axis suppression occurs, gradually withdraw mometasone furoate ointment, reduce the frequency of application or consider use of a less potent corticosteroid. If signs and symptoms of glucocorticosteroid insufficiency occur, supplemental systemic corticosteroids may be required.

Cushing’s Syndrome, Hyperglycemia, and Glucosuria

Systemic effects of topical corticosteroids, including mometasone furoate ointment, may also manifest as Cushing’s syndrome, hyperglycemia, and glucosuria. …

Mometasone side effects

The following serious adverse reactions are discussed in more detail in other sections of the labeling:

•Endocrine System Adverse Reactions

•Ophthalmic Adverse Reactions

•Allergic Contact Dermatitis

•Concomitant Skin infections

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

In controlled clinical trials the incidence of adverse reactions associated with the use of mometasone furoate ointment was 4.8%. Reported reactions included burning, pruritus, skin atrophy, tingling/stinging, and furunculosis. Cases of rosacea associated with the use of mometasone furoate ointment have been reported.

The following adverse reactions have been identified during postapproval use of topical corticosteroids. Because adverse reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

•

Endocrine Disorders: Cushing’s syndrome, linear growth retardation, and delayed weight gain.

•

Local Adverse Reactions: irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, striae, and miliaria.

•

Nervous System Disorders: intracranial hypertension. …

About this medicine

Mometasone Furoate Ointment USP, 0.1% contains 1 mg mometasone furoate per gram in a white to off-white uniform ointment base for topical use. Mometasone furoate is a synthetic corticosteroid with anti-inflammatory activity.

Chemically, mometasone furoate is 9α,21-dichloro-11β,17-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17-(2-furoate), with the empirical formula C27H30Cl2O6, a molecular weight of 521.4 and the following structural formula:

Mometasone furoate is a white to off-white powder practically insoluble in water, slightly soluble in octanol, and moderately soluble in ethyl alcohol.

Mometasone furoate ointment contains the following inactive ingredients: hexylene glycol, phosphoric acid, propylene glycol stearate (55% monoester), purified water, white wax, and white petrolatum.

How it works: Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in dermatoses is unknown. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID d986282f-da3c-43b6-a3f6-40886d4a1915. Read the full official label on DailyMed.